AQST EBITDA Margin
Aquestive Therapeutics Inc · EBITDA Margin
AQST EBITDA Margin
Latest reported-113.50%period ending
AQST TTM EBITDA Margin (4.51% → -113.50%)
TTM ebitda margin
High-resolution chart · PNG
AQST ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -113.4968% | |
| -102.7053% | |
| -148.4701% | |
| -118.3884% | |
| -107.6203% | |
| -67.692% | |
| -46.2396% | |
| -30.944% | |
| -20.0034% | |
| -33.2414% | |
| 2.3348% | |
| -9.9087% | |
| -26.6853% | |
| -44.444% | |
| -83.0055% | |
| -112.2202% | |
| -106.0741% | |
| -89.015% | |
| -88.584% | |
| -74.1275% | |
| -97.0866% | |
| -70.6219% | |
| -85.3803% | |
| -61.4888% | |
| -60.3742% | |
| -112.3987% | |
| -102.4882% | |
| -105.8022% | |
| -99.2017% | |
| -122.5636% | |
| -74.8198% | |
| -73.6804% | |
| -29.3479% | |
| 11.2134% | |
| 4.5069% |